Modernatx, Inc.
Cambridge, MA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 325 Binney St, Cambridge, MA 02142, USA
- Website
- modernatx.com
- Founded
- 2010
- Employees
- 1K-5K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$2,187,534 |
| FY2023 | $54,277,285 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Moderna US, Inc. | Princeton, NJ | 325414 Biological Product (except Diagnostic) Manufacturing |
| Trilink Biotechnologies, LLC | San Diego, CA | 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing |
| IDT Biologika GMBH | Dessau-Roßlau, SA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Inovio Pharmaceuticals, Inc. | Plymouth Meeting, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Corporate | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Modernatx, Inc. is a manufacturer of pharmaceutical goods registered as a corporate entity in SAM.gov since 2012. The company specializes in pioneering messenger RNA therapeutics to produce human proteins or antibodies inside patient cells.
Through prime and subcontract awards, Modernatx has provided COVID-19 mRNA vaccines, accelerated RNA technology, mRNA-encoded antibodies against SARS-CoV-2, and scaled up domestic manufacturing capacity of mRNA vaccines. Major customers include the Department of Veterans Affairs, Defense Advanced Research Projects Agency, Department of the Army, and Department of Health and Human Services. Awards have been made on a firm fixed price, cost-plus-fixed-fee, and other transaction basis, spanning definitive contracts, purchase orders, and other transaction agreements. No set aside designations were indicated across the contract actions.
Modernatx has not received any prime federal grants, though it has participated as a subawardee designing and producing pre-clinical mRNA for coronavirus-related research under University of Texas Medical Branch prime awards.
The company also holds an other transaction IDV from the Defense Advanced Research Projects Agency to perform optimization work around a Phase I clinical trial of an mRNA construct encoding a SARS-CoV-2 antibody candidate. The IDV has a potential value of $7.9 million and aims to expedite COVID-19 therapeutic development.
Quick answers
Is Modernatx, Inc. registered in SAM.gov?
Yes. Modernatx, Inc.'s SAM.gov registration is active through March 22, 2027.
What is Modernatx, Inc.'s CAGE code?
Modernatx, Inc.'s CAGE code is 6RP85, and its Unique Entity ID (UEI) is WJYNZ8AK2D47.
How much has Modernatx, Inc. received in federal contracts?
Federal contracts obligated $52,089,751 to Modernatx, Inc. in fiscal years 2023 through 2027.
What is Modernatx, Inc.'s most recent federal award?
Modernatx, Inc.'s most recent federal contract award is Covid vaccines (36C25023P1813), from Veterans Integrated Service Network 10 (VHA), on August 15, 2023.
On GovTribe
See Modernatx, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors